Embeda (im-BED-a) is a new oral opioid designed to limit abuse

October 2009

Embeda (im-BED-a) is a new oral opioid designed to limit abuse.

But don't be lulled into a false sense of security.

The capsules contain extended-release morphine pellets with an inner core of the opioid antagonist naltrexone.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Influenza using antivirals and vaccines for the current flu season
Interaction alerts often pop up about possible serotonin syndrome when patients get more than one serotonergic drug
Diabetes questions about how to switch between insulins
Women's Health You'll hear more about limiting antidepressants during pregnancy
Women's Health whether Yaz and Yasmin (drospirenone/ethinyl estradiol) are riskier than other combined oral contraceptives
Cardiology whether a DOUBLE dose of clopidogrel (Plavix) improves outcomes in cardiac patients
Generics Many big drugs will go generic in the next few years
Neurology & Pain Embeda (im-BED-a) is a new oral opioid designed to limit abuse
Psychiatry Saphris (SA-fris), a new atypical antipsychotic for schizophrenia and bipolar disorder
Respiratory & Allergy Xopenex (levalbuterol) does NOT work any better than albuterol
Respiratory & Allergy new OTC cough and cold syrup called Clofera (chlophedianol/pseudoephedrine)
Statins More questions about resolving statin myopathy will come up
Ophthalmology Claritin Eye and Zyrtec Itchy Eye Drops don't contain the active ingredient that you'd expect